News Briefs: Biomet IPO; Hep C Screening Coverage; Valve Guidelines
This article was originally published in The Gray Sheet
Biomet’s parent company filed an initial public offering registration statement for the firm March 7. CMS proposes national coverage for hepatitis C screening. ACC and AHA release new heart valve guidelines. More news.
You may also be interested in...
Allergan To Sell Lap-Band Franchise To Apollo For Up To $110 Million
The firm announced Oct. 29 an agreement with Apollo Endosurgery to sell its obesity intervention business, including the Lap-Band adjustable band.
Reimbursement Briefs: National Coverage Updates; MolDx Meeting Request; Sleep Study Questions
Hepatitis C virus screening national coverage supported in comments. Proposed decision memo delayed for percutaneous image-guided lumbar decompression for lumbar spinal stenosis national coverage determination. More reimbursement news.
Investor Eye: A Licensing-Based Approach May Be Best For Revolutionary IP
Keeping a firm grip on one’s IP is a cornerstone of most innovative businesses. However, Robert Cote, CEO of Cote Capital, believes that if the idea is good enough to keep close, it’s good enough to license out.